FROVA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Frova, and when can generic versions of Frova launch?
Frova is a drug marketed by Endo Operations, Amneal Pharms Co, Glenmark Pharms Ltd, Norvium Bioscience, and Renata. and is included in five NDAs.
The generic ingredient in FROVA is frovatriptan succinate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Frova
A generic version of FROVA was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FROVA?
- What are the global sales for FROVA?
- What is Average Wholesale Price for FROVA?
Summary for FROVA
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 2,326 |
Drug Prices: | Drug price information for FROVA |
What excipients (inactive ingredients) are in FROVA? | FROVA excipients list |
DailyMed Link: | FROVA at DailyMed |
Pharmacology for FROVA
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Paragraph IV (Patent) Challenges for FROVA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FROVA | Tablets | frovatriptan succinate | 2.5 mg | 021006 | 1 | 2011-03-09 |
US Patents and Regulatory Information for FROVA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Norvium Bioscience | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 202931-001 | Aug 28, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Amneal Pharms Co | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 211292-001 | Nov 6, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Glenmark Pharms Ltd | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 204730-001 | Mar 11, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Renata | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 213891-001 | Apr 6, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FROVA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FROVA
See the table below for patents covering FROVA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Poland | 171034 | ⤷ Sign Up | |
Portugal | 100620 | DERIVADOS DE TETRA-HIDROCARBAZOL, SEU USO E PREPARACAO E COMPOSICOES FARMACEUTICAS QUE OS CONTEM | ⤷ Sign Up |
Czech Republic | 9601506 | ⤷ Sign Up | |
Singapore | 47877 | Use of tetrahydrocarbazone derivatives as 5HT receptor agonists | ⤷ Sign Up |
Brazil | 1100460 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FROVA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0591280 | C00591280/01 | Switzerland | ⤷ Sign Up | FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH |
0591280 | C300103 | Netherlands | ⤷ Sign Up | PRODUCT NAME: FROVATRIPTAN EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 27211RVG 27212 2002190419; FIRST REGISTRATION: NL 24548 20001212 |
0591280 | SPC/GB03/014 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: 3 METHYLAMINO-6-CARBOXAMIDO-1, 2, 3, 4-TETRAHYDROCARBAZOLE ("FROVATRIPTAN") INCLUDING A SALT, SOLVATE OR HYDRATE THEREOF; REGISTERED: FR NL 24548 20001212; UK PL 16239/0017 20021007; UK PL 16239/0018 20021007 |
0591280 | 01C0019 | France | ⤷ Sign Up | PRODUCT NAME: FROVATRIPTAN SUCCINATE MONOHYDRATE; NAT. REGISTRATION NO/DATE: NL 24548 20001212; FIRST REGISTRATION: FR - NL 24548 20001212 |
0591280 | 37/2002 | Austria | ⤷ Sign Up | PRODUCT NAME: FROVATRIPAN; NAT. REGISTRATION NO/DATE: 1-24487 20020424; FIRST REGISTRATION: FR NL 24548 20001212 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |